ArticleCureus2025
Autoimmune Polyglandular Syndrome Type 3 and Overlapping Autoimmune Endocrinopathies: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune polyglandular syndrome type 3 (APS type 3) is defined by the coexistence of autoimmune thyroid disease with other autoimmune disorders, excluding adrenal insufficiency. It is a common but often under-recognized entity, particularly in young women with multiple autoimmune conditions. We report the case of a 27-year-old woman with a longstanding history of type 1 diabetes mellitus (T1DM) who presented with multiple episodes of diabetic ketoacidosis to the emergency department. She presented with fatigue and had poor glycemic control (HbA1c 11.3%). She was further diagnosed in the ward with refractory autoimmune hypothyroidism, pernicious anemia, celiac disease with poor dietary adherence, and proliferative diabetic retinopathy requiring retinal intervention. Physical examinations, blood workup, and radiological investigations revealed no signs of adrenal insufficiency or pituitary adenoma. The combination of autoimmune thyroid disease, T1DM, pernicious anemia, celiac disease, and systemic autoimmunity, in the absence of adrenal involvement, is consistent with a diagnosis of APS type 3 with overlapping subtypes. This case illustrates the clinical complexity and diagnostic challenges of APS type 3. Early identification and multidisciplinary management of coexisting autoimmune disorders are essential for improving long-term outcomes and reducing complications. Attention to dietary adherence, appropriate thyroid hormone dosing, and ongoing screening for evolving autoimmune involvement are critical elements in the care of such patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.